These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2869440)

  • 1. Opiate antagonists do not alter neuronal responses to stimulation of opioid-containing pathways in rat hippocampus.
    Chavkin C; Bloom FE
    Neuropeptides; 1986 Jan; 7(1):19-22. PubMed ID: 2869440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin-A alters the excitability of pyramidal neurons of the rat hippocampus in vitro.
    Gruol DL; Chavkin C; Valentino RJ; Siggins GR
    Life Sci; 1983; 33 Suppl 1():533-6. PubMed ID: 6141499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine and naloxone on hippocampal CA3 field potentials following systemic administration in the freely-moving rat.
    Linseman MA; Corrigall WA
    Brain Res Bull; 1984 Aug; 13(2):241-5. PubMed ID: 6093941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus.
    Wagner JJ; Caudle RM; Chavkin C
    J Neurosci; 1992 Jan; 12(1):132-41. PubMed ID: 1345943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptors are involved in an NMDA receptor-independent mechanism of LTP induction at hippocampal mossy fiber-CA3 synapses.
    Derrick BE; Weinberger SB; Martinez JL
    Brain Res Bull; 1991 Aug; 27(2):219-23. PubMed ID: 1660336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dynorphin A (1-17), dynorphin A (1-13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus in vitro.
    Vidal C; Maier R; Zieglgänsberger W
    Neuropeptides; 1984 Dec; 5(1-3):237-40. PubMed ID: 6152322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG; Schweitzer P; Siggins GR
    J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
    Stevens KE; Shiotsu G; Stein L
    Brain Res; 1991 Apr; 545(1-2):8-16. PubMed ID: 1677606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat.
    Salin PA; Weisskopf MG; Nicoll RA
    J Neurosci; 1995 Oct; 15(10):6939-45. PubMed ID: 7472450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory action of opioid peptides and opiates on cultured hippocampal pyramidal cells.
    Gähwiler BH
    Brain Res; 1980 Jul; 194(1):193-203. PubMed ID: 6247031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats.
    Hollrigel GS; Chen K; Baram TZ; Soltesz I
    Neuroscience; 1998 May; 84(1):71-9. PubMed ID: 9522363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus.
    Neumaier JF; Mailheau S; Chavkin C
    J Pharmacol Exp Ther; 1988 Feb; 244(2):564-70. PubMed ID: 2894454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are endogenous opiates involved in potentiation of field potentials in the hippocampus of the rat?
    Linseman MA; Corrigall WA
    Neurosci Lett; 1981 Dec; 27(3):319-24. PubMed ID: 6276825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cellular responses to electrophoretically applied dynorphin in the rat hippocampus.
    Henriksen SJ; Chouvet G; Bloom FE
    Life Sci; 1982 Oct 18-25; 31(16-17):1785-8. PubMed ID: 6130440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid peptides and epileptogenesis in the limbic system: cellular mechanisms.
    Siggins GR; Henriksen SJ; Chavkin C; Gruol D
    Adv Neurol; 1986; 44():501-12. PubMed ID: 2939697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.
    Wagner JJ; Terman GW; Chavkin C
    Nature; 1993 Jun; 363(6428):451-4. PubMed ID: 8099201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenously released opioids inhibit inhibitory post synaptic potentials in guinea pig CA3 pyramidal cells and rat dentate granule cells.
    Caudle RM; Swearengen E; Chavkin C
    Prog Clin Biol Res; 1990; 328():5-8. PubMed ID: 2154812
    [No Abstract]   [Full Text] [Related]  

  • 20. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.